Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial-Reference-Cited by-同舟云学术

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial

Published:2020-04 Issue:10233 Volume:395 Page:1374-1381
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Gimbel Marieke,Qaderdan Khalid,Willemsen Laura,Hermanides Rik,Bergmeijer Thomas,de Vrey Evelyn,Heestermans Ton,Tjon Joe Gin Melvyn,Waalewijn Reinier,Hofma Sjoerd,den Hartog Frank,Jukema Wouter,von Birgelen Clemens,Voskuil Michiel,Kelder Johannes,Deneer Vera,ten Berg Jurriën

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;Roffi;Eur Heart J,2016

2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS;Valgimigli;Eur Heart J,2018

3. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

4. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N Engl J Med,2009

5. Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial;Piccolo;EuroIntervention,2017

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Invasive and conservative management of elderly patients presenting with acute coronary syndrome: A meta-analysis of randomized controlled trials and adjusted observational studies;International Journal of Cardiology;2024-12

2. 2023 European Society of Cardiology guidelines for the management of acute coronary syndromes;Netherlands Heart Journal;2024-09-10

3. Advanced technologies for screening and identifying covalent inhibitors;TrAC Trends in Analytical Chemistry;2024-09

4. De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials;The Lancet;2024-09

5. Engineered P2Y₁₂-Overexpressing Cell-Membrane-Wrapped Nanoparticles for the Functional Reversal of Ticagrelor and Clopidogrel;Nano Letters;2024-08-14